These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 23384098)
1. Unraveling the IVIG mystique. Branch DR Transfusion; 2013 Feb; 53(2):242-4. PubMed ID: 23384098 [No Abstract] [Full Text] [Related]
2. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia. Tremblay T; Paré I; Bazin R Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706 [TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases]. Mouthon L; Hurez V; Kazatchkine M Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238 [TBL] [Abstract][Full Text] [Related]
4. Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations. Klaver AC; Finke JM; Digambaranath J; Balasubramaniam M; Loeffler DA Int Immunopharmacol; 2010 Jan; 10(1):115-9. PubMed ID: 19840873 [TBL] [Abstract][Full Text] [Related]
5. Preparation and use of therapeutic antibodies primarily of human origin. Stiehm ER; Keller MA; Vyas GN Biologicals; 2008 Nov; 36(6):363-74. PubMed ID: 18789721 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of IVIG in adult onset Rasmussen's encephalitis. Buenz EJ; Howe CL Can J Neurol Sci; 2007 Feb; 34(1):108-9. PubMed ID: 17352358 [No Abstract] [Full Text] [Related]
7. The evaluation of suspected immune deficiency by the primary care physician. Infante AJ; Kamani NR Compr Ther; 1997 Feb; 23(2):89-94. PubMed ID: 9083718 [No Abstract] [Full Text] [Related]
14. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases]. Lewańska M; Selmaj K Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin treatment on anti-GM1 antibodies associated neuropathies inhibits cholera toxin and galectin-1 binding to ganglioside GM1. Peng W Immunol Lett; 2012 Apr; 143(2):146-51. PubMed ID: 22289946 [TBL] [Abstract][Full Text] [Related]
16. Current perspectives on the use of intravenous immunoglobulin. Dickler HB; Gelfand EW Adv Intern Med; 1996; 41():641-80. PubMed ID: 8903601 [No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulin: striving for appropriate use. Kumar A; Teuber SS; Gershwin ME Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800 [TBL] [Abstract][Full Text] [Related]
18. [Gamma globulins in clinical practice]. Panizon F Pediatr Med Chir; 1993; 15(4):333-5. PubMed ID: 7505432 [No Abstract] [Full Text] [Related]
19. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Soelberg Sorensen P Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]